- MyIllumina
- Tools
The VeraCode ADME Core Panel offers the most complete representation of the ADME content that matters most. Focused on the standardized PharmADME Core list and leveraging the innovative VeraCode technology this panel streamlines drug metabolism biomarker analysis, allowing studies to proceed faster than ever before.
View the product support page for additional technical information ยป
The VeraCode ADME Core Panel offers the most complete representation of the ADME content that matters most. Focused on the standardized PharmADME Core list and leveraging the innovative VeraCode technology this panel streamlines drug metabolism biomarker analysis, allowing studies to proceed faster than ever before.
With the VeraCode ADME Core Panel researchers analyze key ADME content in as little as one day. In addition, the VeraCode ADME Core Panel provides a number of internal controls to ensure precise, verifiable results.
Catalog IDs: VC-901-0200, VC-901-0201
Product Literature
| VeraCode ADME Brochure |
| Veracode ADME Core Panel Data Sheet |
Innovative technologies
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
© 2012 Illumina, Inc. All rights reserved.